
Sun Pharma's $3.7B Organon bid leads whale moves Jun 17
Wednesday's filings are led by Sun Pharma's $3.7B all-cash take-private of Organon ($14.00/sh, special meeting July 23) and the Smith family's on-record declaration that Sonic Automotive is "undervalued" with a take-private "on the table" at 42% ownership. Silver Lake filed 5 more Dell Form 4s (~95K shares, ~$38M). Cevian nudged its Smith & Nephew stake to 12.24%. PayPal CFO bought $255K in PYPL discretionary shares. Gossamer Bio completed its $181M convert exchange; final settlement June 18.

Sun Pharmaceutical's $3.7 billion all-cash bid for Organon (Nasdaq: OGN) — filed as a definitive proxy on Wednesday — tops a session that added a quantum-tech SPAC merger, a Holcim full-tender for a Peruvian cement company, three fresh activist/large-holder 13D amendments, a CFO open-market buy at PayPal, and Silver Lake's continued drip-selling of Dell. The Smith family's public declaration that Sonic Automotive shares are "undervalued" and that a take-private is "on the table" is the sharpest directional signal in the batch.
Quick scan: all items, Jun 16–17
| Ticker | Filer / entity | Action | Key metric | Filing date |
|---|---|---|---|---|
| OGN | Sun Pharmaceutical Holdings USA | DEFM14A: $3.7B all-cash take-private | $14.00/sh; special meeting Jul 23 | Jun 17 |
| ALOT | Arcline Investment Management affiliates | 8-K: $272M all-cash acquisition | $29.00/sh; 209% premium to Apr 6 price | Jun 17 |
| SVAQ / EIGQ | Silicon Valley Acquisition Corp. + EigenQ | 8-K + 425: $3B SPAC merger | ~$110M gross proceeds; close Q4 2026 | Jun 17 |
| CPAC | Holcim / Inversiones ASPI | 13D/A: full tender offer planned | 50.01% stake; any-and-all; price TBD | Jun 17 |
| SAH | Smith family group (OBS Family + Sonic Financial + B./D./M. Smith) | 13D/A (Amend. 5): 40.9%–42.3% stake; take-private under review | 13.2M–13.4M shares each; could exceed 50% | Jun 17 |
| SNN | Cevian Capital II entities via Aurora Nominees | 6-K: 12.24% voting stake disclosed | 103.7M shares; up from 12.07% | Jun 17 |
| CMTL | White Hat Capital Partners LP | 13D/A (Amend. 5): 9.99% stake + debt restructure | $65M sub-debt at 16%; B-4 preferred at $7.99/sh | Jun 16 |
| VRM | Mudrick Capital Management entities | Form 4 ×2: added 15,595 shares + 15,595 warrants | $7.22/sh; total 3.98M shares | Jun 16 |
| PYPL | Jamie Miller (CFO & COO) | Form 4: 6,129 shares open-market purchase | $41.53/sh; ~$255K | Jun 16 |
| DELL | Silver Lake (5 entities) | Form 4 ×5: ~95K Class C shares sold Jun 12 | ~$399–408/sh; ~$38M; Class B converting | Jun 16 |
| GOSS | Gossamer Bio | 8-K: $181M convert exchange completed | 5% 2027 → 7.5% 2030 + equity; final settlement Jun 18 | Jun 17 |
| HUN / OLN | Olin / Huntsman combined entity | 425: OlinHuntsman name confirmed; H1 2027 close | $12B+ all-stock; $400M+ synergies; unchanged | Jun 17 |
| ENHA | Apeiron Investment Group (Christian Angermayer) | 13D/A: 24.4% stake + private placement | 5.14M shares + warrants at $3.89; close ~Jun 22 | Jun 16 |
Coverage: Jun 16 13:38 UTC → Jun 17 13:00 UTC
Sun Pharma bids $14.00/sh for Organon — $3.7B, special meeting Jul 23
Organon & Co. (Nasdaq: OGN) filed its definitive merger proxy on Wednesday, formalizing Sun Pharmaceutical Holdings USA, Inc.'s offer of $14.00 per share in cash — an implied equity value of approximately $3.7 billion based on 262.6 million shares outstanding as of the June 15 record date. 1
Sun Pharmaceutical Holdings USA is an indirect subsidiary of Sun Pharmaceutical Industries Ltd., one of the largest specialty-generic pharma companies globally. The transaction carries $12 billion in committed bridge financing from Sun Pharma and requires no financing condition — the board unanimously recommends shareholders vote FOR. 1
Key deal mechanics: Morgan Stanley issued a fairness opinion on April 26, 2026 and stands to receive an advisory fee of approximately $39.4 million contingent on close. A termination fee of $120 million is payable by Organon under certain conditions. The agreement was signed April 26; the proxy was mailed June 17. Close is expected early 2027, pending HSR and other regulatory approvals. 1
Smith family eyes Sonic Automotive take-private with 42% stake

The Smith family group — comprising OBS Family LLC, Sonic Financial Corporation, and three family members (B. Scott Smith, David Bruton Smith, Marcus G. Smith) — filed a 13D/A (Amendment No. 5) disclosing individual beneficial ownership of 40.9%–42.3% of Sonic Automotive (NYSE: SAH), a publicly traded auto dealership group. 2
The group has not purchased new shares recently — the ownership increase reflects SAH's own buybacks reducing float and thereby lifting each reporting person's percentage. But the language they chose to put on record is unambiguous:
"The Reporting Persons presently believe that the Shares are undervalued at current market prices and represent an attractive investment opportunity... such acquisitions could result in the Reporting Persons acquiring greater than 50% beneficial ownership... alternatives could include, among other things, a transaction to take the Issuer private." 2
The group's current position breaks down as: OBS Family LLC holds 9.5% (3.0 million Class A shares), Sonic Financial Corp. holds 31.2% (9.9 million Class A shares via Class B conversion). Of 31.6 million combined shares outstanding (Class A + convertible Class B), the group controls more than 40% of the effective float.
Cevian bumps Smith & Nephew stake to 12.24%
Cevian Capital II — the activist-oriented Swedish fund — disclosed a modest increase in its Smith & Nephew (NYSE: SNN) stake via a UK threshold-crossing notification (TR-1) filed June 17. 3 The threshold was crossed June 12; the issuer was notified June 16.
Cevian's indirect voting rights now stand at 103,717,469 shares = 12.235936%, up from 12.074433% at the prior notification. The master fund (Cevian Capital II Master Fund L.P.) holds 11.05%; a co-investment vehicle (Series P) holds the remaining 1.19%. All rights are held in shares — no financial instruments or synthetic exposure. 3
Cevian has been a SNN holder since at least the firm's initial Q1 2026 13F disclosure. The continued slow accumulation — without any public board demands yet on record — is consistent with Cevian's typical build-first, engage-later pattern.
Three more deals: Arcline/AstroNova, EigenQ SPAC, Holcim/CPAC tender
AstroNova (Nasdaq: ALOT), a specialty printing and data equipment company, agreed June 16 to be acquired by affiliates of Arcline Investment Management LP for $29.00 per share in cash — approximately $272 million enterprise value. 4 The bid represents a 209% premium to AstroNova's unaffected share price on April 6, 2026, and roughly 120% over the 90-day VWAP through June 16. Arcline-backed funds provide a limited guarantee with no financing condition; reciprocal termination fees are set at $9.648 million. The outside date is 150 days from June 16 (plus a 30-day extension option). Board unanimously approved; subject to shareholder vote and HSR clearance.
Silicon Valley Acquisition Corp. (Nasdaq: SVAQ) signed a definitive business combination agreement with EigenQ Inc., a quantum security and technology company, at a pro forma enterprise value of approximately $3 billion. 5 EigenQ's strategic partners include HPE, AMD, and TD SYNNEX; the company is targeting a CNSA 2.0 (Commercial National Security Algorithm Suite 2.0, the US government's post-quantum cryptography standard) procurement gate in January 2027. Expected gross proceeds to EigenQ: approximately $110 million from the SVAQ trust, PIPE, and a $12.00/share private placement. Existing EigenQ shareholders are rolling substantially all of their equity. Post-close ticker: EIGQ on Nasdaq. Target close: Q4 2026, pending S-4 effectiveness and shareholder approvals. 5
Holcim Ltd. and its Peruvian affiliate Inversiones ASPI S.A. filed a 13D/A disclosing that the Holcim Executive Committee decided on June 15 to launch a public tender offer for any and all outstanding common shares of Cementos Pacasmayo (NYSE: CPAC), a Peruvian cement producer. 6 Holcim and ASPI together currently hold 211,985,547 shares = 50.01% of 423.9 million shares outstanding. The offer price has not yet been disclosed — it will be set in subsequent tender offer materials. 6
Distressed and activist positions: CMTL, VRM, ENHA
White Hat Capital Partners LP filed a 13D/A (Amendment No. 5) on Comtech Telecommunications (Nasdaq: CMTL), detailing a heavily restructured debt and equity position. 7 White Hat holds 5.056 million shares (9.99% beneficial, capped by a blocker provision), including 4.71 million shares issuable from conversion of Series B-3 Preferred. The fund's $65 million subordinated term loans now carry a 16.0% make-whole interest rate (18% on default), with make-whole premiums of 50% before April 1, 2027 and 75% thereafter. The Series B-3 Preferred was exchanged for Series B-4 Convertible Preferred at a $7.99 per share conversion price. Lender warrants add 125,000 shares at $0.10, vesting October 2026. Financial covenants have been suspended until the 4-quarter period ending July 31, 2027. The transaction is connected to Comtech's sale of its Wavestream/Gilat assets via a $65 million Purchase Agreement. 7
Mudrick Capital Management entities bought 15,595 common shares and 15,595 warrants of Vroom (Nasdaq: VRM) on June 15 in a privately negotiated transaction. 8 9 Shares were acquired at $7.22 each; warrants at $0.01 (exercise price $60.95, expiring January 2030). Total transaction value was approximately $112,752. Mudrick's cumulative VRM position across its various funds and managed accounts now totals 3,982,846 common shares. Mudrick entities are both directors and 10% owners of Vroom.
Apeiron Investment Group Ltd. (Malta), controlled by investor Christian Angermayer, reported a 24.4% beneficial stake in Enhanced Holdings (Nasdaq: ENHA) via a 13D/A filed June 16. 10 The increase stems from a Securities Purchase Agreement signed June 14 for a private placement of 5,141,388 shares plus an equal number of warrants at a combined price of $3.89. The deal closes in two tranches: approximately 3.0 million shares around June 22, and 2.1 million more after stockholder consent is effective. Resale registration is required within 30 days of closing. 10
Insider signal: PayPal CFO buys $255K open market

Jamie S. Miller, PayPal Holdings' (Nasdaq: PYPL) Chief Financial & Operating Officer, purchased 6,129 shares at $41.53 on June 15 — a $254,537 open-market buy, per a Form 4 filed June 16. 11 The purchase was not made under a pre-arranged 10b5-1 plan. Miller simultaneously received a one-time grant of 146,778 Performance Stock Units, with a performance period running March 1, 2029 to March 1, 2031 and payout ranging from 0% to 250% based on stock-price hurdles. After the transaction, Miller holds 80,123 common shares directly plus the PSU grant and remaining RSU tranches. 11
No other C-suite PayPal Form 4s were filed in the window. At $41.53, PYPL was trading at roughly 40% below its 52-week high — the CFO's discretionary buy at this level is a data point, though a single transaction by one officer is not a cluster signal.
Watch-list updates

DELL / Silver Lake — Five Silver Lake entities filed Form 4s on June 16 covering sales on June 12: combined approximately 95,003 Class C shares sold at $399–408 per share (roughly $38 million in total proceeds). 12 Entity breakdown: SLP IV (~39,537 shares), SL SPV-2 (~34,257), SLP V DE AIV (~20,095), SLTI IV (~764), SLTI V (~345). Accompanying Class B → Class C conversions totaled approximately 131,895 shares across all five entities. Additionally, DELL director David W. Dorman sold 41,292 Class C shares on June 12 via a GRAT trust at $405–408; the trust now holds zero DELL shares. Silver Lake's combined remaining Class B position across all entities: approximately 26.87 million shares. A $3 billion debt offering (three tranches: $1B 4.750% due 2031, $750M 5.000% due 2034, $1.25B 5.250% due 2037) via Dell International L.L.C. and EMC was filed as an 8-K on June 16. A 13D/A #15 remains due approximately June 20. 12
GOSS / D.E. Shaw settlement — Gossamer Bio (Nasdaq: GOSS) announced the final results of its convertible note exchange on June 17. 13 $181,052,000 of 5.00% Convertible Senior Notes due 2027 were tendered (90.5% of the $200 million outstanding after the minimum condition was amended from 98% to 90.5%). These are being exchanged for: up to $72 million of new 7.50% Convertible Senior Secured First Lien Notes due 2030, plus up to 317,647,058 common shares (or pre-funded warrants), plus early-tender warrants. The remaining $18,948,000 of old notes stays outstanding. Final settlement is June 18 — the deadline cited in the prior watch-list. A special stockholder meeting to approve related proposals is set for July 14, 2026. 13
OLN / HUN — OlinHuntsman — Huntsman filed a 425 on Wednesday morning (a LinkedIn post by Olin) confirming the combined company name: OlinHuntsman Corporation. No new material terms — the $12B+ all-stock exchange ratio (0.5476 Olin shares per Huntsman share), $400M+ synergies target, and H1 2027 close remain as previously announced. 14
IOT / Andreessen — No new Form 4s from Andreessen's LAMA Community Trust since June 12. Of the 4,512,974-share Form 144 block, approximately 2,256,487 shares have been sold (50%), leaving roughly 2,256,487 shares still under the plan.
NNDM / Murchinson — No Murchinson proxy materials (DEFC14A) filed as of the window close. The EGM record date is June 23 (six days out). EGM date remains July 31; 30-day exclusivity with Infinite Epigenetics runs through approximately July 15.
NRDY / CEO Cohn — No Day 5 filing as of June 17 13:00 UTC. The four-day buy streak ended at ~978,311 cumulative shares (~$978K). Whether it resumes Thursday is an open question.
BLND / Haveli — No new Form 4s from Haveli in the window (most recent: June 15). Stake remains approximately 22.5% (64.2 million shares including preferred conversion). No public board demands on record.
ROKU / Fox merger — ROKU CFO & COO Dan Jedda sold 7,000 Class A shares at $143.87 on June 15 under a pre-existing 10b5-1 plan. Post-sale direct holdings: 79,963 shares. No new 425 merger communications and no HSR filing yet for the $22B Fox deal.
PAYO / Nuvei — TCV-affiliated funds filed a 13D/A on June 16 disclosing a 10.2% stake in Payoneer (Nasdaq: PAYO) (34,197,116 shares as of April 30) and a Voting and Support Agreement to vote for Nuvei's $2.75B take-private at $7.40/sh. 15 No TCV transactions in the past 60 days; the HSR filing for the Nuvei deal is still pending.
Secondary items in window
Several items from the window are noted without full detail:
- FTHM / Bed Bath & Beyond: A 425 filed June 17 references a combination to build an "end-to-end home ecosystem." The detail page was inaccessible at time of collection; no terms confirmed.
- NVIDIA (NVDA): Filed a $25 billion multi-tranche investment-grade notes offering (424B5, June 16) across maturities from 2028 to 2056. Not a position disclosure.
- LPRO / Open Lending: Bregal-backed buyout at $3.15/share (13D/A filed June 16). Terms not fully verified at time of collection.
- MBAV / M3-Brigade: Filed a 13D/A on June 16 disclosing it dropped the ReserveOne merger and is seeking a 12-month SPAC extension.
Cover: AI-generated illustration — institutional pre-market intelligence theme.
参考来源
- 1Organon DEFM14A: $14.00 cash merger; special meeting July 23, 2026
- 2Smith family group 13D/A: 40.9%–42.3% SAH stake, take-private under review
- 3Cevian Capital 6-K: 12.24% voting stake in Smith & Nephew
- 4AstroNova 8-K: $272M all-cash acquisition by Arcline
- 5SVAQ / EigenQ 8-K: $3B SPAC merger; close Q4 2026
- 6Holcim / ASPI 13D/A: full tender offer for Cementos Pacasmayo
- 7White Hat 13D/A: 9.99% CMTL stake, $65M sub-debt at 16%, Series B-4 preferred
- 8Mudrick Capital Form 4: VRM stock purchase
- 9Mudrick Capital Form 4: VRM stock and warrants purchase
- 10Apeiron 13D/A: 24.4% ENHA stake + $3.89 private placement
- 11PayPal Form 4: CFO Jamie Miller buys 6,129 shares at $41.53
- 12Silver Lake Form 4 (SLP IV): Dell Class C shares sold Jun 12
- 13Gossamer Bio 8-K: $181M convert exchange completed; final settlement Jun 18
- 14Huntsman 425: OlinHuntsman combination confirmed; H1 2027 close
- 15Payoneer SEC filings — TCV 13D/A and Voting Support Agreement
围绕这条内容继续补充观点或上下文。